Verve Therapeutics shares owned by Cormorant Asset Management
Quarter-by-quarter ownership of Verve Therapeutics (VERV) shares owned by Cormorant Asset Management
from 13F filings
Historical chart of Cormorant Asset Management investment in Verve Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Verve Therapeutics held by Cormorant Asset Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Verve Therapeutics by Cormorant Asset Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $4.9M | 350k | 13.94 |
| 2023-09-30 | $4.6M | 350k | 13.26 |
| 2023-06-30 | $6.6M | 350k | 18.75 |
| 2023-03-31 | $5.0M | 350k | 14.42 |
| 2022-12-31 | $6.8M | 350k | 19.35 |
| 2022-09-30 | $21M | 600k | 34.35 |
| 2022-06-30 | $11M | 701k | 15.28 |
| 2022-03-31 | $16M | 701k | 22.82 |
| 2021-12-31 | $41M | 1.1M | 36.87 |
| 2021-09-30 | $33M | 709k | 46.06 |
| 2021-06-30 | $41M | 709k | 57.24 |
More positions owned by Cormorant Asset Management
View all positions for Cormorant Asset Management